抗癫痫新药拉考沙胺概述

被引：8

作者：

庞素凤

刘海净

吴叶红

雷兵团

机构：

[1] 开滦集团有限公司医院

来源：

药物流行病学杂志 | 2010年 / 19卷 / 08期

关键词：

拉考沙胺; 癫痫/部分性发作; 作用机制; 临床研究;

D O I：

10.19960/j.cnki.issn1005-0698.2010.08.020

中图分类号：

R971 [神经系统药物];

学科分类号：

1007 ;

摘要：

<正>拉考沙胺(lacosamide)也称拉科酰胺,商品名Vimpat。2008年10月28日获FDA批准,由德国Schwarz BioSciences公司研发生产,是近3年来首个治疗癫痫部分发作的抗癫痫新药,对未控制的癫痫部分发作患者提供了治疗新手段。拉考沙胺的新颖

引用

页码：476 / 478

页数：3

共 5 条

[1]

Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety[J] . Christoph Kellinghaus.Therapeutics and Clinical Risk Management . 2009 (defa)

[2]

Efficacy and Safety of Lacosamide in Diabetic Neuropathic Pain: An 18-week Double-blind Placebo-controlled Trial of Fixed-dose Regimens[J] . James P. Wymer,Jeffrey Simpson,David Sen,Sabine Bongardt.The Clinical Journal of Pain . 2009 (5)

[3]

Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures[J] . Beydoun,D’Souza,Hebert,Doty.Expert Review of Neurotherapeutics . 2009 (1)

[4] Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures [J].

Ben-Menachem, Elinor ;

Biton, Victor ;

Jatuzis, Dalius ;

Abou-Khalil, Bassel ;

Doty, Pamela ;

Rudd, G. David .

EPILEPSIA, 2007, 48 (07) :1308-1317

[5] Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF [J].

Beyreuther, Bettina K. ;

Geis, Christian ;

Stoehr, Thomas ;

Sommer, Claudia .

NEUROPHARMACOLOGY, 2007, 52 (05) :1312-1317

← 1 →